We are very pleased to be hosting another in our series of educational masterclasses in Prague next week. Across three days, we will run masterclasses aimed at healthcare professionals involved in the diagnosis and treatment of patients with spinal muscular atrophy (SMA) and Duchenne muscular dystrophy (DMD).
The SMA masterclass is chaired by Professor Laurent Servais, and the DMD masterclass by Professor Annemieke Aartsma-Rus—both of whom are leading experts in their respective fields. The programme will feature talks from key opinion leaders on topics such as the patient perspective and communicating with families, new and emerging therapies, genetics, as well as a series of interactive workshops. There will be plenty of opportunities for delegates to network and ask questions throughout both events.
Both events were oversubscribed, and we are pleased to have been able to cover delegate costs to attend, ensuring the event is accessible to all. This has been made possible thanks to the generous support of our sponsors: F. Hoffmann-La Roche Ltd (Roche), Biogen Inc., Scholar Rock, Sarepta Therapeutics, Keros Therapeutics, Sanofi, and Entrada Therapeutics. As both events will be accredited by the European Accreditation Council for Continuing Medical Education (EACCME), sponsors have had no involvement in determining the content of the masterclasses, the speaker selection, or the delegate application review process.
We are continually planning future educational events, all with the aim of improving diagnosis and care for patients with neuromuscular disease. If you’re interested in sponsoring a future event, or have any comments or suggestions on what would be beneficial to the community, please get in touch: info@treat-nmd.com
Accreditation Statement
The TREAT-NMD Spinal Muscular Atrophy Expert Masterclass
“The TREAT-NMD Spinal Muscular Atrophy Expert Masterclass, Prague, Czech Republic, Czech Republic 08/07/2025 -09/07/2025, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 8.5 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.”
The TREAT-NMD Duchenne Muscular Dystrophy Expert Masterclass
“The TREAT-NMD Duchenne Muscular Dystrophy Expert Masterclass, Prague, Czech Republic, Czech Republic 09/07/2025 -10/07/2025, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 7.5 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.”
Applies to both
“Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications .
“Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.”
